Figure 5.

Cost-effectiveness plane for patients with APACHE II ≥ 25 – 10,000 Monte Carlo simulations (20-year time horizon, 3% discounting). The points to the left of the vertical line correspond to a lower efficacy and higher cost with drotrecogin alfa compared to placebo.

Costa and Brophy BMC Anesthesiology 2007 7:5   doi:10.1186/1471-2253-7-5
Download authors' original image